Trade Summary

Yesterday, Levy Raphi, serving as Chief Financial Officer at Alpha Tau Medical Ltd. (DRTS), sold 20,000 shares at $11.00 per share, for a total transaction value of $220,004.00. Following this transaction, Levy Raphi now holds 110,180 shares of DRTS.

This sale represents a 15.36% decrease in Levy Raphi's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 25, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 8:17 AM ET, 1 day after the trade was made.